Helix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Helix and buy or sell other stocks, ETFs, and their options commission-free!About HLXA
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases.
CEOJorge Santos da Silva, PhD
CEOJorge Santos da Silva, PhD
Employees100
Employees100
HeadquartersZug, Zug
HeadquartersZug, Zug
Founded2021
Founded2021
Employees100
Employees100
HLXA Key Statistics
Market cap841.03M
Market cap841.03M
Price-Earnings ratio-20.63
Price-Earnings ratio-20.63
Dividend yield—
Dividend yield—
Average volume409.64K
Average volume409.64K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$58.26
52 Week high$58.26
52 Week low$31.42
52 Week low$31.42
People also own
Based on the portfolios of people who own HLXA. This list is generated using Robinhood data, and it’s not a recommendation.